Back
Theriva Biologics Stock Price Chart
![](/images/offers/ims/large/offer14.jpg)
Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
TOVX
Theriva Biologics
Last Price:
$1.50
Seasonality Move:
-9.16%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer9.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.38 | Buy |
20-day SMA: | 1.42 | Buy |
50-day SMA: | 1.4 | Buy |
200-day SMA: | 4.01 | Sell |
8-day EMA: | 1.41 | Buy |
20-day EMA: | 1.41 | Buy |
50-day EMA: | 1.5 | Sell |
200-day EMA: | 4.2 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.69 | Buy |
Chaikin Money Flow: | -44255 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.3 - 1.6) | Sell |
Bollinger Bands (100): | (1.05 - 2.11) | Sell |
Theriva Biologics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.43 while TOVX 8-day simple moving average is 1.38, which is a Buy signal.
-
The stock price of TOVX is 1.43 while Theriva Biologics 20-day SMA is 1.42, which makes it a Buy.
-
Theriva Biologics 50-day simple moving average is 1.40 while TOVX share price is 1.43, making it a Buy technically.
-
TOVX stock price is 1.43 and Theriva Biologics 200-day simple moving average is 4.01, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
34
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a SellThe current Theriva Biologics [TOVX] share price is $1.43. The Score for TOVX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
4M
Price in USD:
1.43
Share Volume:
81.3K
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
1.14
Sell
34
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?The Theriva Biologics stock price is 1.43 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.43 while TOVX 8-day exponential moving average is 1.41, which is a Buy signal.
-
The stock price of TOVX is 1.43 while Theriva Biologics 20-day EMA is 1.41, which makes it a Buy.
-
Theriva Biologics 50-day exponential moving average is 1.50 while TOVX share price is 1.43, making it a Sell technically.
-
TOVX stock price is 1.43 and Theriva Biologics 200-day simple moving average is 4.20, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Theriva Biologics is a Sell
-
Theriva Biologics Relative Strength Index (RSI) is 50.69, which suggest Theriva Biologics is overbought
-
The Bollinger Bands (25) for Theriva Biologics is (1.3 - 1.6), which suggest Theriva Biologics is a Sell
-
The Bollinger Bands (100) for Theriva Biologics is (1.05 - 2.11), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.